1. Home
  2. CRMT vs ONCY Comparison

CRMT vs ONCY Comparison

Compare CRMT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$11.79

Market Cap

103.5M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.06

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
ONCY
Founded
1981
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Specialty Stores
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.5M
94.0M
IPO Year
2026
2002

Fundamental Metrics

Financial Performance
Metric
CRMT
ONCY
Price
$11.79
$1.06
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$29.50
$7.33
AVG Volume (30 Days)
134.8K
885.3K
Earning Date
03-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
147.36
N/A
EPS
N/A
N/A
Revenue
$1,390,932,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.58
$0.33
52 Week High
$62.55
$1.51

Technical Indicators

Market Signals
Indicator
CRMT
ONCY
Relative Strength Index (RSI) 35.95 56.88
Support Level $11.04 $0.94
Resistance Level $13.63 $1.13
Average True Range (ATR) 0.85 0.09
MACD 0.26 0.02
Stochastic Oscillator 41.07 87.53

Price Performance

Historical Comparison
CRMT
ONCY

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: